海正药业: 浙江海正药业股份有限公司关于回购股份事项前十大股东和前十大无限售条件股东持股情况的公告

Group 1 - The company Zhejiang Haizheng Pharmaceutical Co., Ltd. has announced the decision to repurchase shares through centralized bidding, as approved in the second meeting of the tenth board of directors and the tenth supervisory board [1] - The announcement includes details about the top ten shareholders and the top ten unrestricted shareholders as of May 12, 2025, prior to the share repurchase decision [1] - The repurchase plan and report have been published in major financial newspapers and on the Shanghai Stock Exchange website [1] Group 2 - The announcement provides a list of the top ten shareholders, including their names, shareholding quantities, and ownership percentages [2] - The top ten unrestricted shareholders are also listed, detailing their shareholding quantities and the proportion of unrestricted circulating shares [2] - The announcement is officially made by the board of directors of Zhejiang Haizheng Pharmaceutical Co., Ltd. on May 17, 2025 [2]